PCM
KLRS

Penserra Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Penserra Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-65
Closed -$37K – 1577
2021
Q3 		$37K Buy
65
+1
+2% +$569 ﹤0.01% 1140
2021
Q2 		$29K Hold
64
– – ﹤0.01% 1100
2021
Q1 		$34K Sell
64
-1
-2% -$531 ﹤0.01% 881
2020
Q4 		$57K Buy
+65
New +$57K ﹤0.01% 677